•  
  •  
  •  
  •  

2026-08-05 14:18:13

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore

Keywords Selected:  4Observations

Stock Report

  • Granules India Limited completes cGMP Audit at its Chantilly Site
  • Strides Pharma Inc's Chestnut Ridge facility gets 4 observations from USFDA
  • Lupin gets 4 observations from USFDA from PAI at Pune Biotech facility
  • Lupin receives Form 483 with 4 observations from USFDA for Pithampur Unit-2
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • Unichem Laboratories Ltd receives 4 observations from USFDA for Pithampur API facility
  • Dr. Reddy's Laboratories Limited gets Form 483 from USFDA with 4 observations for API facility
  • Zydus Lifesciences Ltd receives 4 observations from USFDA post inspection at SEZ Onco Injectable site
  • Indoco Remedies Ltd's Sterlie Facility at Goa receives Form 483 with 4 observations from USFDA
  • US FDA inspection completed at Caplin Steriles Injectable site at Gummidipoondi
  • Aurobindo Pharma Ltd gets Form 483 with 4 observations from USFDA for inspection at Unit XIV
  • Dr. Reddy's Laboratories Ltd gets Form 483 with 4 observations from USFDA for Srikakulam formulations facility
  • Indoco Remedies Ltd gets Form 483 with 4 observations for Plants 2 and 3 at Goa
  • USFDA inspects Alembic Pharmaceuticals' Oncology Injectable Formulation Facility at Panelav
  • Zydus Lifesciences Ltd gets 4 observations from USFDA for Moraiya facility

Latest Post

  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025